المؤلفون: Kuzminov, E. D., Shugurov, A. R., Derbin, A. Yu., Panin, A. V., Dmitriev, A. I.

المصدر: Russian Physics Journal ; ISSN 1064-8887 1573-9228

الاتاحة: https://doi.org/10.1007/s11182-024-03345-4
https://link.springer.com/content/pdf/10.1007/s11182-024-03345-4.pdf
https://link.springer.com/article/10.1007/s11182-024-03345-4/fulltext.html

المؤلفون: Kuzminov, E. D.¹ (AUTHOR) evgenij_kuzminov00@mail.ru, Derbin, A. Y.¹ (AUTHOR), Shugurov, A. R.¹ (AUTHOR)

المصدر: Russian Physics Journal. Jun2024, Vol. 67 Issue 6, p784-790. 7p.

مصطلحات موضوعية: *MAGNETRON sputtering, *DC sputtering, *SURFACE coatings, *SUBSTRATES (Materials science), *SCANNING electron microscopy, *X-ray spectroscopy

المؤلفون: Altukhov, P. D., Kuzminov, E. G.

مصطلحات موضوعية: Condensed Matter - Other Condensed Matter

URL الوصول: http://arxiv.org/abs/0806.2050

المؤلفون: Altukhov, P. D., Kuzminov, E. G.

المصدر: Phys. Stat. Sol. (b) 232, # 2, 364-379 (2002)

مصطلحات موضوعية: Condensed Matter - Other Condensed Matter

URL الوصول: http://arxiv.org/abs/0801.3057

المؤلفون: Kuzminov, E. D., Derbin, A. Y., Shugurov, A. R.

المصدر: Russian Physics Journal ; volume 67, issue 7, page 1082-1082 ; ISSN 1064-8887 1573-9228

الاتاحة: https://doi.org/10.1007/s11182-024-03218-w
https://link.springer.com/content/pdf/10.1007/s11182-024-03218-w.pdf
https://link.springer.com/article/10.1007/s11182-024-03218-w/fulltext.html

المؤلفون: Shugurov, A. R., Garanin, Yu. A., Kuzminov, E. D.

المصدر: Russian Physics Journal ; volume 67, issue 4, page 373-380 ; ISSN 1064-8887 1573-9228

الاتاحة: http://dx.doi.org/10.1007/s11182-024-03133-0
https://link.springer.com/content/pdf/10.1007/s11182-024-03133-0.pdf
https://link.springer.com/article/10.1007/s11182-024-03133-0/fulltext.html

المؤلفون: Shugurov, A. R., Kuzminov, E. D., Garanin, Yu. A.

المصدر: AIP Conference Proceedings ; PHYSICAL MESOMECHANICS OF CONDENSED MATTER: Physical Principles of Multiscale Structure Formation and the Mechanisms of Nonlinear Behavior: MESO2022 ; volume 2899, page 020134 ; ISSN 0094-243X

الاتاحة: http://dx.doi.org/10.1063/5.0162823
http://aip.scitation.org/doi/pdf/10.1063/5.0162823

المؤلفون: A. Kuzminov E., T. Borisova N., V. Breder V., E. Reutova V., T. Barbolina D., K. Laktionov K., А. Кузьминов Е., Т. Борисова Н., В. Бредер В., Е. Реутова В., Т. Барболина Д., К. Лактионов К.

المصدر: Meditsinskiy sovet = Medical Council; № 9 (2020); 190-195 ; Медицинский Совет; № 9 (2020); 190-195 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: localized small cell lung cancer, prophylactic brain irradiation, early chemoradiotherapy, late chemoradiotherapy, simultaneous chemoradiotherapy, consecutive chemoradiotherapy, локализованный мелкоклеточный рак легкого, профилактическое облучение головного мозга, ранняя химиолучевая терапия, поздняя химиолучевая терапия, одновременная химиолучевая терапия, последовательная химиолучевая терапия

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/5735/5233; Warde P., Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol. 1992;10(6):890–895. doi:10.1200/JCO.1992.10.6.890.; Pignon J.P., Arriagada R., Ihde D.C., Johnson D.H., Perry M.C., Souhami R.L. et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992;327(23):1618–1624. doi:10.1056/NEJM199212033272302.; Fried D.B., Morris D.E., Poole C., Rosenman J.G., Halle J.S., Detterbeck F.C. et al. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol. 2004;22(23):4837–4845. doi:10.1200/JCO.2004.01.178.; Stinchcombe T.E., Gore E.M. Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms. Oncologist. 2010;15(2):187–195. doi:10.1634/theoncologist.2009-0298.; Murray N., Coy P., Pater J.L., Hodson I., Arnold A., Zee B.C. et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 1993;11(2):336–344. doi:10.1200/JCO.1993.11.2.336.; Pijls-Johannesma M., De Ruysscher D., Vansteenkiste J., Kester A., Rutten I., Lambin P. Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials. Cancer Treat Rev. 2007;33(5):461–473. doi:10.1016/j.ctrv.2007.03.002.; Spiro S.G., James L.E., Rudd R.M., Trask C.W., Tobias J.S., Snee M. et al. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. J Clin Oncol. 2006;24(24):3823–3830. doi:10.1200/JCO.2005.05.3181.; Schild S.E., Bonner J.A., Shanahan T.G., Brooks B.J., Marks R.S., Geyer S.M. et al. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;59(4):943–951. doi:10.1016/j.ijrobp.2004.01.055.; De Ruysscher D., Lueza B., Le Péchoux C., Johnson D.H., O’Brien M., Murray N. et al. Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis. Ann Oncol. 2016;27(10):1818–1828. doi:10.1093/annonc/mdw263.; De Ruysscher D., Pijls-Johannesma M., Bentzen S.M., Minken A., Wanders R., Lutgens L. et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol. 2006;24(7):1057–1063. doi:10.1200/JCO.2005.02.9793.; Bonner J.A., Sloan J.A., Shanahan T.G., Brooks B.J., Marks R.S., Krook J.E. et al. Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma. J Clin Oncol. 1999;17(9):2681–2681. doi:10.1200/JCO.1999.17.9.2681.; Kies M.S., Mira J.G., Crowley J.J., Chen T.T., Pazdur R., Grozea P.N. et al. Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reducedfield radiation in partial responders: a Southwest Oncology Group Study. J Clin Oncol. 1987;5(4):592–600. doi:10.1200/JCO.1987.5.4.592.; Turrisi A.T., Kim K., Blum R., Sause W.T., Livingston R.B., Komaki R. et al. Twice-daily compared with once-daily thoracic radiotherapy in limited smallcell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999;340:265–271. doi:10.1056/NEJM199901283400403.; Faivre-Finn C., Snee M., Ashcroft L., Ashcroft L., Appel W., Barlesi F. et al. Concurrent Once-Daily Versus Twice-Daily Chemoradiotherapy in Patients With Limited-Stage Small-Cell Lung Cancer (CONVERT): An Open-Label, Phase 3, Randomised, Superiority Trial Lancet Oncol. 2017;18(8):1116– 1125. doi:10.1016/S1470-2045(17)30318-2.; Arriagada R., Le Chevalier T., Borie F., Rivière A., Chomy P., Monnet I. et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst. 1995;87(3):183–190. doi:10.1093/jnci/87.3.183.; Aupérin A., Arriagada R., Pignon J.P., Le Péchoux С., Gregor A., Stephens R.J. et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med. 1999;341(7):476–484. doi:10.1056/NEJM199908123410703.; Wolfson A.H., Bae K., Komaki R., Meyers С., Movsas В., Le Pechoux С. et al. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011;81(1):77–84. doi:10.1016/j.ijrobp.2010.05.013.; Zhang W., Jiang W., Luan L., Wang L., Zheng X., Wang G. Prophylactic cranial irradiation for patients with small-cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer. 2014;14:793. doi:10.1186/1471-2407-14-793.; Sun A., Bae K., Gore E.M., Movsas B., Wong S.J., Meyers C.A., Bonner J.A. et al. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non–small-cell lung cancer: neurocognitive and quality-of-life analysis. J Clin Oncol. 2010;29(3):279– 286. doi:10.1200/JCO.2010.29.6053.; Gondi V., Paulus R., Bruner D.W., Meyers C.A., Gore E.M., Wolfson A. et al. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. Int J Radiat Oncol Biol Phys. 2013;86(4):656–664. doi:10.1016/j.ijrobp.2013.02.033.; Le Péchoux C., Dunant A., Senan S., Wolfson A., Quoix E., Faivre-Finn C. et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003- 08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. Lancet Oncol. 2009;10(5):467–474. doi:10.1016/S1470-2045(09)70101-9.; https://www.med-sovet.pro/jour/article/view/5735

الاتاحة: https://www.med-sovet.pro/jour/article/view/5735
https://doi.org/10.21518/2079-701X-2020-9-190-195

المؤلفون: A. Markovich A., A. Kuznetsova A., V. Gorbunova A., N. Orel F., A. Odintsova S., G. Emelyanova S., A. Kuzminov E., А. Маркович А., А. Кузнецова А., В. Горбунова А., Н. Орел Ф., А. Одинцова С., Г. Емельянова С., А. Кузьминов Е.

المصدر: Meditsinskiy sovet = Medical Council; № 10 (2019); 115-119 ; Медицинский Совет; № 10 (2019); 115-119 ; 2658-5790 ; 2079-701X ; 10.21518/2079-701X-2019-10

مصطلحات موضوعية: neuroendocrine tumors, sunitinib, safety profile, нейроэндокринные опухоли, сунитиниб, профиль безопасности

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/3061/2985; Sharma J., Duque M., Saif M.W. Emerging therapies and latest development in the treatment of unresectable pancreatic neuroendocrine tumors: an update for clinicians. Therap. Adv. Gastroenterol. 2013;6(6):474–490.; Fjallskog M.L., Lejonklou M.H., Oberg K.E., Eriksson B.K., Janson E.T. Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors. Clin. Cancer Res. 2003;9(4):1469–1473.; Kulke M.H., Lenz H.J., Meropol N.J. et al. Activity of sunitinib in patients with advanced neuroendocrine tumors. J. Clin. Oncol. 2008;26(20):3403–3410.; Raymond E., Dahan L., Raoul J.L. et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N. Engl. J. Med. 2011;364(6):501–513.; Faivre S., Niccoli P., Castellano D. et al. Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a Phase III randomized study. Ann. Oncol. 2016;28(2):339–343.; Raymond E., Kulke M.H., Qin S. et al. Efficacy and safety of sunitinib in patients with welldifferentiated pancreatic neuroendocrine tumours. Neuroendocrinology. 2018;107(3):237–245.; Rinzivillo M., Fazio N., Pusceddu S. et al. Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: a real-world study. Pancreatology. 2018;18(2):198–203.; Valle J.W., Faivre S., Hubner R.A., Grande E., Raymond E. Practical management of sunitinib toxicities in the treatment of pancreatic neuroendocrine tumors. Cancer Treat. Rev. 2014;40(10):1230–1238.; Valle J.W., Borbath I., Rosbrook B., Fernandez K., Raymond E. Sunitinib in patients with pancreatic neuroendocrine tumors: update of safety data. Future Oncology. 2019;15(11):1219-1230.; https://www.med-sovet.pro/jour/article/view/3061

الاتاحة: https://www.med-sovet.pro/jour/article/view/3061
https://doi.org/10.21518/2079-701X-2019-10-115-119

المؤلفون: Shugurov, A. R., Kuzminov, E. D., Garanin, Yu. A., Panin, A. V., Dmitriev, A. I.

المصدر: Russian Physics Journal ; ISSN 1064-8887 1573-9228

الاتاحة: http://dx.doi.org/10.1007/s11182-023-02828-0
https://link.springer.com/content/pdf/10.1007/s11182-023-02828-0.pdf
https://link.springer.com/article/10.1007/s11182-023-02828-0/fulltext.html

المؤلفون: G. Emelianova S., N. Orel F., V. Gorbunova A., A. Kolomeytseva A., A. Kuznetsova A., A. Kuzminov E., A. Fedenko A., Г. Емельянова С., Н. Орел Ф., В. Горбунова А., А. Коломейцева А., А. Кузнецова А., А. Кузьминов Е., А. Феденко А.

المصدر: Siberian journal of oncology; Том 16, № 6 (2017); 100-104 ; Сибирский онкологический журнал; Том 16, № 6 (2017); 100-104 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2017-16-6

مصطلحات موضوعية: neuroendocrine tumors, bevacizumab, нейроэндокринные опухоли, бевацизумаб

وصف الملف: application/pdf

Relation: https://www.siboncoj.ru/jour/article/view/647/496; Zhang J., Jia Z., Li Q., Wang L., Rashid A., Zhu Z., Evans D.B., Vauthey J.N., Xie K., Yao J.C. Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors. Cancer. 2007 Apr 15; 109 (8): 14708–86.; Koumarianou A., Kaltsas G. Bevacizumab Plus Temozolomide: A Novel Treatment Option for Advanced Neuroendocrine Tumors? J Clin Oncol. 2013 Mar 1; 31 (7): 975–6. doi:10.1200/JCO.2012.45.7523.; Chan J.A., Stuart K., Earle C.C., Clark J.W., Bhargava P., Miksad R., Blaszkowsky L., Enzinger P.C., Meyerhardt J.A., Zheng H., Fuchs C.S., Kulke M.H. Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors. J Clin Oncol. 2012 Aug 20; 30 (24): 2963–8. doi:10.1200/JCO.2011.40.3147.; Yao J.C., Phan A., Hoff P.M., Chen H.X., Charnsangavej C., Yeung S.C., Hess K., Ng C., Abbruzzese J.L., Ajani J.A. Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. J Clin Oncol. 2008 Mar 10; 26 (8): 1316–23. doi:10.1200/JCO.2007.13.6374.; Berruti A., Fazio N., Ferrero A., Brizzi M.P., Volante M., Nobili E., Tozzi L., Bodei L., Torta M., D’Avolio A., Priola A.M., Birocco N., Amoroso V., Biasco G., Papotti M., Dogliotti L. Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. BMC Cancer. 2014 Mar 14; 14: 184. doi:10.1186/1471-2407-14-184.; Mitry E., Walter T., Baudin E., Kurtz J.E., Ruszniewski P., Dominguez-Tinajero S., Bengrine-Lefevre L., Cadiot G., Dromain C., Farace F., Rougier P., Ducreux M. Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial)--a phase II non-randomised trial. Eur J Cancer. 2014 Dec; 50 (18): 3107–15. doi:10.1016/j.ejca.2014.10.001.; Abstracts of the 13th Annual ENETS Сonference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease. 2016 March 9–11; Barcelona, Spain.; https://www.siboncoj.ru/jour/article/view/647

الاتاحة: https://www.siboncoj.ru/jour/article/view/647
https://doi.org/10.21294/1814-4861-2017-16-6-100-104

المؤلفون: Kuzminov, E. D., Shugurov, A. R., Кузьминов, Е. Д., Шугуров, А. Р.

وصف الملف: application/pdf

Relation: Физика. Технологии. Инновации. Тезисы докладов (ФТИ-2021); Кузьминов Е. Д. ВЛИЯНИЕ АРХИТЕКТУРЫ МНОГОСЛОЙНЫХ ПОКРЫТИЙ НА ОСНОВЕ Ti-Al-Ta-N НА ИХ МЕХАНИЧЕСКИЕ И ТРИБОЛОГИЧЕСКИЕ ХАРАКТЕРИСТИКИ / Е. Д. Кузьминов, А. Р. Шугуров // Физика. Технологии. Инновации : тезисы докладов VIII Международной молодежной научной конференции (Екатеринбург, 17–21 мая 2021 г.). — Екатеринбург : УрФУ, 2021. — C. 827-828.; http://elar.urfu.ru/handle/10995/124213

الاتاحة: http://elar.urfu.ru/handle/10995/124213

المؤلفون: Shugurov, A. R., Kuzminov, E. D., Kasterov, A. M., Akulinkin, A. A.

المصدر: AIP Conference Proceedings ; PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON PHYSICAL MESOMECHANICS. MATERIALS WITH MULTILEVEL HIERARCHICAL STRUCTURE AND INTELLIGENT MANUFACTURING TECHNOLOGY ; volume 2310, page 020314 ; ISSN 0094-243X

الاتاحة: http://dx.doi.org/10.1063/5.0034262
http://aip.scitation.org/doi/pdf/10.1063/5.0034262

المؤلفون: Shugurov, A. R., Kuzminov, E. D.

المصدر: AIP Conference Proceedings ; PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON PHYSICAL MESOMECHANICS. MATERIALS WITH MULTILEVEL HIERARCHICAL STRUCTURE AND INTELLIGENT MANUFACTURING TECHNOLOGY ; volume 2310, page 020313 ; ISSN 0094-243X

الاتاحة: http://dx.doi.org/10.1063/5.0034252
http://aip.scitation.org/doi/pdf/10.1063/5.0034252

المؤلفون: Zagoruiko Yu. A., Fedorenko O. A., Kovalenko N. O., Kuzminov E. A., Mateychenko P. V.

المصدر: Tekhnologiya i Konstruirovanie v Elektronnoi Apparature, Iss 1, Pp 47-48 (2010)

مصطلحات موضوعية: active element of the laser, ZnSe:Cr2+, ZnO, anti-reflective coating, Electrical engineering. Electronics. Nuclear engineering, TK1-9971

Relation: http://www.tkea.com.ua/tkea/2010/1_2010/pdf/13.zip; https://doaj.org/toc/2225-5818; https://doaj.org/article/dcfa174dce2249e0a7de73ed23fa8247

الاتاحة: https://doaj.org/article/dcfa174dce2249e0a7de73ed23fa8247

المؤلفون: Shugurov, A. R., Panin, A. V., Kuzminov, E. D., Kasterov, A. M., Akulinkin, A. A., Eremin, A. V., Burkov, M. V., Kalashnikov, M. P.

المصدر: AIP Conference Proceedings ; PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON ADVANCED MATERIALS WITH HIERARCHICAL STRUCTURE FOR NEW TECHNOLOGIES AND RELIABLE STRUCTURES 2019 ; volume 2167, page 020333 ; ISSN 0094-243X

الاتاحة: http://dx.doi.org/10.1063/1.5132200
http://aip.scitation.org/doi/pdf/10.1063/1.5132200

المؤلفون: Shugurov, A. R., Panin, A. V., Kuzminov, E. D., Kasterov, A. M., Akulinkin, A. A., Eremin, A. V., Burkov, M. V., Kalashnikov, M. P.

المصدر: AIP Conference Proceedings; 2019, Vol. 2167 Issue 1, p020333-1-020333-4, 4p, 1 Diagram, 1 Chart, 2 Graphs

مصطلحات موضوعية: TITANIUM alloys, SURFACE coatings, MAGNETRON sputtering, SCANNING electron microscopy, RESIDUAL stresses, DIGITAL cameras

المؤلفون: Altukhov, P. D., Kuzminov, E. G.

المصدر: physica status solidi (b). 232:364-379

مصطلحات موضوعية: Condensed Matter - Other Condensed Matter, Condensed Matter::Materials Science, Physics::Instrumentation and Detectors, Condensed Matter::Other, Physics::Plasma Physics, Physics::Optics, FOS: Physical sciences, Condensed Matter Physics, Other Condensed Matter (cond-mat.other), Electronic, Optical and Magnetic Materials

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21d53a1e70590665aad2ff4d39c52ad3
https://doi.org/10.1002/1521-3951(200208)232:2<364::aid-pssb364>3.0.co;2-g

المؤلفون: Воробьева, Е. А., Кузьминов, Е. А., Vorobeva, E. A., Kuzminov, E. A.

مصطلحات الفهرس: Болонский процесс, система высшего образования, Министерство образования, бакалавриат, магистратура, интернет-опросы, Thesis

URL: http://edoc.bseu.by:8080/handle/edoc/24492

المؤلفون: Smolensky, G. A., Siny, I. G., Pisarev, R. V., Kuzminov, E. G.

المصدر: Ferroelectrics ; volume 12, issue 1, page 135-136 ; ISSN 0015-0193 1563-5112

الاتاحة: https://doi.org/10.1080/00150197608241407
http://www.tandfonline.com/doi/pdf/10.1080/00150197608241407